Vella, Laura J <br/><br/>
Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.  [electronic resource] 

 -  Expert review of clinical immunology  Aug 2014 
 - 1107-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1744-8409 
<br/><br/><label>Standard No.: </label>10.1586/1744666X.2014.929943  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Drug Discovery<br/>Humans<br/>Immunotherapy--methods<br/>Melanoma--immunology<br/>Molecular Targeted Therapy<br/>Neoplasm Metastasis<br/>Protein Kinase Inhibitors--therapeutic use<br/>Signal Transduction--drug effects<br/>Skin Neoplasms--immunology